The FDA has approved azilsartan medoxomil (Edarbi), an oral angiotensin II receptor blocker (ARB) for hypertension, expanding the ranks of ARBs now available to U.S. patients.
TAK-491 would have been a better brand name IMHO.
LinkUp – Try This for Remote Underwriting Jobs
Find Job Openings | LinkUp Job Search Engine
If you’re looking for work try this job search engine. It pulls job listings from company websites.
Very cool.
Six Secrets to a Bulletproof Career
The Six Secrets to a Bulletproof Career – Guest Blog Post by Andrew Neitlich | paulacaligiuri.com
Check out this blog post.
Provident Capital Indemnity Ltd. Charged With Life Settlement Fraud
Thought for Today 2/20/11
Information Arbitrage – Preparing for and adapting to tomorrow’s world
Read Think Apply Plan Act.
(hat tip abnormalreturns.com)
Magnesium and Sudden Cardiac Death
Plasma and dietary magnesium and risk of sudden cardiac death in women — Am J Clin Nutr
Conclusions: In this prospective cohort of women, higher plasma concentrations and dietary magnesium intakes were associated with lower risks of SCD. If the observed association is causal, interventions directed at increasing dietary or plasma magnesium might lower the risk of SCD.
MIB December 2010 Life Index
Mom Was Right – Eat Your Veggies
Remember life is short and science takes too long. Eat more fruit and vegetables to lower your IHD risk.
Among the more than 300,000 participants in the study, those who consumed eight or more portions of fruit and vegetables each day had a reduction of 22% in their risk of fatal ischemic heart disease (RR 0.78, 95% CI 0.65 to 0.95) compared with those who ate fewer than three portions, according to Francesca L. Crowe, PhD, of the University of Oxford in England, and colleagues.
Vorapaxar Phase III Update
Whoops.
The novel antithrombotic vorapaxar causes intracranial hemorrhage in patients with a history of stroke, Merck announced, explaining why stroke survivors were dropped from trials of the experimental drug.
Vilazodone (Viibryd) = New Antidepressant
Medical News: FDA Approves New Antidepressant – in Product Alert, Prescriptions from MedPage Today
Vilazodone (Viibryd) has been approved for treatment of major depression, the FDA announced.
lifeunderwriter.net 
You must be logged in to post a comment.